Cytodyn can not afford to sell Leronlimab.

New Post Public Reply Private Reply Replies (0) Message Board
My69z
564
 Cytodyn can not afford to sell Leronlimab.

Everyone's sp preference will be attained on this journey:

$5,$10,$20 --$50, $100+ & etc...

Pharma will Plug-n-Play Leronlimab & LA-LRM into their existing infrastructure(s).

$$.
Revenue.
NASDAQ uplist.
Listings on multiple markets.

CYDY:
Largest pharmaceutical dividends in history.

&

 Supply availability optics:
*Direct indications.
*At-risk populations.
*Repurposed combo trials.

We focus on which company should partner/buy Leronlimab.

There's an even more lucrative angle being overlooked --- the number of companies who need a guarantee of supply, is unlimited.

Cytodyn has 12 yrs of manufacturing rights @ 1st full FDA approval.

If you do not have a direct equity partnership with Cytodyn, you better pre-pay to secure supply.

So when only 1 or 2 companies are mentioned as hopeful partners --- think about how many that excludes.....

Companies within many types of industries will need Sequence LL, for their own combinations. Be it clinical & market approvals.

12 yrs --- & Generics are not a mfgr'ing concern either.

AKA:
Profits on the scale of manufacturing volume, absolutely dwarfs a one-time buy-out offer to Cytodyn shareholders.

Cytodyn shareholders, can not afford to sell Leronlimab  

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Scope Technologies Welcomes New VP of Product Andrew Knight

Updated Category News Views 232

Scope Technologies Strengthens Product Leadership Scope Technologies Corp. has appointed Andrew Knight as the new Vice President of Product, a decision to enhance its leadership team during a transformative phase for the company. Knight, with nearly twenty years of comprehensive experience in technology, will be at the helm of this strategic evolution. Meeting the Demands...

Continue Reading
FPX Nickel Achieves Significant Milestone in Nickel Sulphate Production

Updated Category News Views 61

FPX Nickel's Breakthrough in Nickel Sulphate Production FPX Nickel Corp. has announced a major milestone in its ongoing efforts to produce battery-grade nickel sulphate. The company has successfully completed pilot-scale hydrometallurgy refinery testwork at its Baptiste Nickel Project, demonstrating its commitment to advancing eco-friendly mining practices. This...

Continue Reading
DraftKings Enriches User Experience with Spanish Feature Launch

Updated Category News Views 117

DraftKings Expands Offerings with Spanish Language Support DraftKings Inc. (NASDAQ: DKNG) has taken a significant step towards catering to a broader audience by introducing a Spanish-language experience within its sportsbook and casino app. This enhancement aims to provide a more personalized and inclusive service for Spanish-speaking customers, reflecting the company's...

Continue Reading
Detailed Insights into International Paper Company Disclosures

Updated Category News Views 177

Key Information on International Paper Company International Paper Company is a significant entity in the global market, noted for its engagement in various sectors including manufacturing and distributing paper products. This article sheds light on the recent disclosure made by Danske Bank A/S regarding its position in the relevant securities of International Paper...

Continue Reading
Civics Knowledge Surge: Trust in Supreme Court Declines

Updated Category News Views 167

Increased Civics Knowledge Among Americans Recent findings indicate that Americans are becoming more knowledgeable about basic civics principles. According to an insightful survey, a notable percentage of the population can now correctly identify the three branches of government: the executive, judicial, and legislative. This shift indicates an upward trend in civic...

Continue Reading